Seeking Alpha
 

Inspire Pharmaceuticals, Inc. (ISPH)

- NASDAQ
ISPH is defunct.
  • Apr. 5, 2011, 9:37 AM
    Merck (MRK -0.4%) says it will acquire Inspire Pharmaceuticals (ISPH), a developer of ophthalmic products, in an all-cash deal for $5/share, or ~$430M. The offer represents a 26% premium to yesterday's closing price. Trading in ISPH halted. (PR)
    | Comment!
  • Jan. 3, 2011, 8:04 AM
    Inspire Pharmaceuticals (ISPH) says its second Phase 3 clinical trial with Denufosol for cystic fibrosis didn't achieve statistical significance for its primary efficacy endpoint. The company calls the results 'disappointing and unexpected.' Shares -55.4% to $3.75. (PR)
    | Comment!
  • Mar. 15, 2010, 9:00 AM
    Premarket gainers: ALKS +16%. AMLN +14%. CXG +10%. BPAX +8%. STJ +8%. PVH +6%. CTIC +5%. NVAX +4%. BIXU +4%. BZH +4%.
    Losers: BSX -19%. ISPH -15%. FBC -10%. CNX -6%.
    | Comment!
  • Jan. 21, 2010, 9:00 AM
    Premarket gainers: IMMU +12%. STX +11%. CYTR +9%. EBAY +9%. PLXS +8%. FCS +7%. FITB +6%. FFIV +4%. KEY +4%. SNE +4%.
    Losers: ISPH -15%. SVA -8%. GRMN -7%. BCS -4%. RTP -4%. RBS -4%.
    | Comment!
  • Aug. 5, 2009, 9:00 AM
    Premarket gainers: INO +42%. RDN +37%. GRMN +20%. PMI +18%. WFMI +16%. USU +14%. BZ +11. TRA +11%. LYG +11%. FWLT +10%. OWW +10%. AIB +8%. RBS +7%. FIG +6%. BCS +5%. CNO +6%. HW +5%. SATC +5%. SAY +4%. ABAT +4%. DVN +4%.
    Losers: ACAS -21%. ISPH -9%. PWR -6%. AXL -6%. HCP -5%. BMC -5%. RIG -4%.
    | Comment!
  • Jun. 17, 2008, 9:56 AM
    Companies most loved by institutions: IXYS Corp. (IXYS), Progenics Pharmaceuticals (PGNX), Inspire Pharmaceuticals (ISPH), Talbots (TLB), AbitibiBowater (ABH).
    | Comment!
Visit Seeking Alpha's
Company Description
Currently, there's no company description for ISPH.